On the evening of 7 November 2024, The Asset, a renowned Asian financial magazine, held “The Asset ESG Corporate Awards 2024” awards ceremony at the Four Seasons Hotel Singapore. Fosun International Limited (“Fosun International” or the “Company”) (HKEX stock code: 00656) was awarded “The Asset ESG Corporate Awards 2024 – Platinum Award” and “Best Initiati

On the morning of November 7, 2024, at the 7thChina International Import Expo (CIIE), Henlius (2696.HK) entered into a strategic collaboration with AL-TIRYAQ AL-KHALAWI Medical Company ("SVAX"), a subsidiary entity of Saudi Arabia's prominent family business group in the healthcare sector, the Fakeeh Family. The two parties will establish joint ventures in Sau

On November 5, the 7th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center in Shanghai. As a seven-time attendee of the CIIE, Fosun showcased the latest achievements in innovation and global operations at its Fosun Pharma booth in Hall 7.1, featuring cutting-edge medical devices and innovative pharmaceuticals that made their debut in China.

On November 6, 2024, during the Seventh China International Import Expo ("CIIE"), Standard Chartered Bank (China) Limited Co. ("Standard Chartered China") and Fosun International Limited ("Fosun International") signed a memorandum of understanding for strategic cooperation ("MOU") to further deepen the bank-enterprise cooperation based on the existing cooperation and to expand the depth and breadth of cooperation in the global market, especially in the "Belt and Road" market.

On 1 November 2024, The Hong Kong Management Association (HKMA) held the “2024 Best Annual Reports Awards” ceremony in Hong Kong. Fosun International was awarded the “Best Environmental, Social and Governance Reporting Awards” by HKMA, in recognition of the company’s outstanding performance in ESG strategy, environmental protection, social responsibility,

(October 30, 2024, Shanghai China) On October 29, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its operating performance for the first three quarters of 2024. From January to September 2024, Fosun Pharma achieved revenue of RMB30.91billion, an increase of about

The “Pursuit of Excellence - 2024 Global Zhejiang Business ESG Conference” was held at the Zhejiang University School of Management, under the guidance of the Zhejiang Daily Press Group and organized by Zheshangmagazine and other partners. Fosun International was recognized in the “2024 Global Zhejiang Business ESG Classic 100” for its significant contributions and

On the afternoon of 12 October, the Press Conference of China Top 500 Private Enterprises 2024 was held in Lanzhou. During the press conference, the All-China Federation of Industry and Commerce released the 2024 lists of "China Top 500 Private Enterprises,” "China Top 500 Private Manufacturing Enterprises" and "China Top 100 Private Service Enterpr

Fidelidade, Fosun, and Hospital da Luz Boost Innovation CultureThe new edition of this Open Innovation program, led by Fidelidade and Fosun, focuses on technological solutions related to Artificial Intelligence and Sustainability in the fields of insurance and healthcare.Lisbon, October 10, 2024 – TheFidelidade Group- in partnership w